- Trials with a EudraCT protocol (73)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
73 result(s) found for: Pressure Ulcer.
Displaying page 1 of 4.
EudraCT Number: 2022-002321-10 | Sponsor Protocol Number: PR11/2022 | Start Date*: 2023-01-16 | |||||||||||||||||||||||||||||||
Sponsor Name:Hospital Universitari d'Igualada | |||||||||||||||||||||||||||||||||
Full Title: Effectiveness and safety of topical sevoflurane for the treatment of painful skin ulcers; randomized, double-blind, placebo-controlled clinical trial | |||||||||||||||||||||||||||||||||
Medical condition: Cutaneous complex ulcers (grade II, III and IV) which are painful and require hospital care | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000202-20 | Sponsor Protocol Number: RC-P0041 | Start Date*: 2015-06-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL) | |||||||||||||||||||||||||||||||||
Full Title: Effect and tolerance of ketamine's subcutaneous bolus during painful care, refractory of bedsore, ulcer, vascular wound care in palliative care units. | |||||||||||||||||||||||||||||||||
Medical condition: Patients’ palliative care for bedsores, ulcers or vascular wounds, which are general characteristics of the patient population that will be included: usually elderly, undernourished and of multiple... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014276-22 | Sponsor Protocol Number: 06FB/DE02 | Start Date*: 2010-02-19 | |||||||||||
Sponsor Name:Laboratoires Genevrier | |||||||||||||
Full Title: Prospective, randomised, multi-centre, blind-observer, controlled, parallel-group study comparing the efficacy and the safety of DERMAGEN® versus conventionnal treatment in the treatment of diabeti... | |||||||||||||
Medical condition: Diabetic neuropathic foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004143-36 | Sponsor Protocol Number: CL2-42909-016 | Start Date*: 2017-05-30 | |||||||||||
Sponsor Name:Ilkos Thérapeutique Inc. | |||||||||||||
Full Title: Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration in patients with active venous leg ulcer. A 10-week randomized, double-blind, placebo-controlled... | |||||||||||||
Medical condition: Venous leg ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DK (Prematurely Ended) CZ (Completed) SK (Completed) ES (Completed) PL (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-003636-38 | Sponsor Protocol Number: SBG-1-13 | Start Date*: 2008-09-22 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: Estudio aleatorizado, doble ciego, controlado con placebo para evaluar la eficacia y seguridad de beta-1,3/1,6- glucano soluble (SBG) en úlceras crónicas del pie en pacientes con diabetes. A random... | |||||||||||||
Medical condition: Úlceras crónicas del pie en pacientes con diabetes Chronic foot ulcers in patients with diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001653-27 | Sponsor Protocol Number: MarsyasII | Start Date*: 2019-12-20 | |||||||||||
Sponsor Name:Aposcience AG | |||||||||||||
Full Title: A randomized, placebo-controlled, double-blind study to evaluate safety and dose dependent clinical efficacy of APO-2 at three different doses in patients with diabetic foot ulcer (MARSYAS II) | |||||||||||||
Medical condition: Diabetic Foot Ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) CZ (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004782-11 | Sponsor Protocol Number: 2002C014G | Start Date*: 2017-12-05 | |||||||||||
Sponsor Name:Prometic Biotherapeutics Ltd | |||||||||||||
Full Title: A Phase 1/2A Prospective, Dose-Escalation, Open-Label Study of the Safety, Feasibility, and Initial Efficacy of Subcutaneous Plasminogen (Human) 10 for the Treatment of Diabetic Foot Ulcer | |||||||||||||
Medical condition: Diabetic foot ulcer (DFU) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010062-33 | Sponsor Protocol Number: ABH-DERMAGRAFT-001-08 | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:Advanced BioHealing Inc | |||||||||||||
Full Title: A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft® in Subjects with Venous Leg Ulcers | |||||||||||||
Medical condition: Venous leg ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SE (Completed) GB (Completed) EE (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001392-32 | Sponsor Protocol Number: SC-VLU-001 | Start Date*: 2021-11-10 | ||||||||||||||||
Sponsor Name:SolasCure Ltd | ||||||||||||||||||
Full Title: An adaptive open label, multiple ascending dose study of the safety, tolerability and bio-effect of Aurase for wound debridement in patients with venous leg ulcers and diabetic foot ulcers (CLEANVL... | ||||||||||||||||||
Medical condition: Venous Leg Ulcer Diabetic Foot Ulcer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-000091-40 | Sponsor Protocol Number: RS03-2004 | Start Date*: 2005-11-08 | |||||||||||
Sponsor Name:ApoPharma Inc. | |||||||||||||
Full Title: Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal – LSR) in the Treatment of Chronic Diabetic Foot Ulcers | |||||||||||||
Medical condition: Chronic Diabetic Foot Ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000692-15 | Sponsor Protocol Number: 05-DFU-001 | Start Date*: 2006-05-03 |
Sponsor Name:Intercytex | ||
Full Title: A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers | ||
Medical condition: Diabetic foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003387-22 | Sponsor Protocol Number: | Start Date*: 2007-10-07 |
Sponsor Name:Pharma 2100 ApS | ||
Full Title: Et velkendt lægemiddels helende effekt på iskæmiske sår: et randomiseret dobbelt-blindt placebokontrolleret pilotforsøg | ||
Medical condition: Out-patients with ischemic (arterial) leg ulcers (systolic toe pressure: < 40 mm Hg). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007748-85 | Sponsor Protocol Number: DT-DP-D02 | Start Date*: 2008-06-26 | ||||||||||||||||||||||||||
Sponsor Name:DermaTools Biotech GmbH | ||||||||||||||||||||||||||||
Full Title: A Prospective, Randomized, Open Label, Add-On, Parallel Arm, In-Patient Comparison Phase II Study to Evaluate the Safety and Efficacy of Diperoxochloric Acid (DermaPro®) in Wounds with Impaired Hea... | ||||||||||||||||||||||||||||
Medical condition: Wounds with Impaired Healing | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003415-22 | Sponsor Protocol Number: AP-W-CLI-2018-8 | Start Date*: 2019-03-22 | |||||||||||
Sponsor Name:Aurealis Oy | |||||||||||||
Full Title: A Phase 1/2A clinical study to evaluate the safety, tolerability and efficacy of single and repeated doses of AUP1602-C as topical treatment of diabetic foot ulcers | |||||||||||||
Medical condition: Diabetic foot ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005580-16 | Sponsor Protocol Number: REDDSTAR-01 | Start Date*: 2016-08-03 | |||||||||||
Sponsor Name:Steno Diabetes Center A/S | |||||||||||||
Full Title: A Phase 1b, open label, uncontrolled non-randomised single dose study to examine the safety of topically applied bone marrow derived allogeneic mesenchymal stromal cells (REDDSTAR ORBCEL-M) seeded ... | |||||||||||||
Medical condition: Patients with non-healing neuroischaemic diabetic foot wounds | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005784-10 | Sponsor Protocol Number: A6301083 | Start Date*: 2007-12-21 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A 6 MONTH, PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF FRAGMIN IN THE TREATMENT OF CHRONIC NEUROISCHAEMIC... | |||||||||||||
Medical condition: Diabetic Foot Ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) NL (Completed) GB (Prematurely Ended) DK (Prematurely Ended) LT (Prematurely Ended) FI (Prematurely Ended) FR (Completed) ES (Completed) GR (Completed) CZ (Completed) AT (Completed) BE (Completed) IT (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006754-26 | Sponsor Protocol Number: PLA/01/06 | Start Date*: 2006-11-28 | |||||||||||
Sponsor Name:MASTELLI SRL | |||||||||||||
Full Title: DIABETIC FOOT ULCERS AND POLYDEOXYRIBONUCLEOTIDE (PLACENTEX INTEGRO MASTELLI) AS A TREATMENT FOR WOUND HEALING | |||||||||||||
Medical condition: Diabetic foot ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) SI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005775-34 | Sponsor Protocol Number: TJ16042008G | Start Date*: 2009-01-16 |
Sponsor Name:ZooBiotic Limited | ||
Full Title: A Randomised Controlled Trial of Larval Therapy in the Debridement of Leg Ulcers. | ||
Medical condition: The purpose of the trial is to evaluate the effectiveness of the BioFOAM dressing in achieving rapid debridement of chronic wounds typified by leg ulcers. Removal of slough and necrotic tissue fro... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000536-10 | Sponsor Protocol Number: LL-37002 | Start Date*: 2018-08-13 | |||||||||||
Sponsor Name:Promore Pharma AB | |||||||||||||
Full Title: A Study in Patients with Hard-to-Heal Venous Leg Ulcers to Measure Efficacy and Safety of Locally Administered LL-37; A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre Trial | |||||||||||||
Medical condition: Hard-to-Heal (HTH) venous leg ulcer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005226-19 | Sponsor Protocol Number: SitaDFU_v1.0 | Start Date*: 2016-07-19 |
Sponsor Name:Medical University of Innsbruck | ||
Full Title: Accelerated wound healing in diabetic ulcers by Sitagliptin | ||
Medical condition: diabetic foot ulcer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.